| Henri Akouka joined MicroDose Therapeutx in 2007, acquired by Teva in 2013, and is Director, Combination Products and Devices R&D for Teva Pharmaceuticals focusing on Design and Development of Biopharmaceutical Combination Products from early clinical through launch. He leads a team of 11 technical staff to develop injectable Biologic and Biosimilar Combination Products and transfer them to Teva’s manufacturing sites for commercial launch. He is an experienced Combination Product Development Professional with 23 years of product development history in semiconductor test equipment as well as electromechanical inhalers and injector systems and is the inventor / co-inventor on over 8 US patents. He also has experience with e-connected drug delivery systems including Cybersecurity risk assessments. He holds a Bachelor of Science in Mechanical Engineering from Norwich University and is licensed as a Professional Engineer in the state of New Jersey. |
